Medication Guide - 6/10/2022

Medication guides are FDA- approved documents that address issues that are specific to particular drugs, and can help patients avoid serious adverse events (side effects). This database does not include Medication Guides for FDA-approved allergenic or cellular/tissue products (see  FDA Online Label Repository  or DailyMed  for these Medication Guides).  More Drug Name Active Ingredient Form;Route Appl. No. Company Date Opdivo Nivolumab INJECTABLE;INJECTION 125554 BRISTOL MYERS SQUIBB 05/27/2022 Yervoy Ipilimumab INJECTABLE; INJECTION 125377 BRISTOL MYERS SQUIBB 05/27/2022 Lemtrada Alemtuzumab INJECTABLE;INJECTION 103948 GENZYME 05/26/2022 Tibsovo Ivosidenib TABLET;ORAL 211192 SERVIER 05/25/2022 Revlimid Lenalidomide CAPSULE;ORAL 021880 CELGENE 05/24/2022 Keytruda Pembrolizumab SOLUTION;INTRAVENOUS 125514 MERCK SHARP DOHME 05/20/2022 Prolia Denosumab INJECTABLE; SUBCUTANEOUS 125320 AMGEN 05/19/2022 Olumiant Baricitinib TABLET;ORAL 207924 ELI LILLY AND CO 05/10/2022 Brilinta Ticagrelor TABLET;ORAL 022433 ASTRAZENECA 05/09/2022 Manage Subscriptions  |  Unsubscribe All  |  Help This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA